FedEx Pilots and Union Reach Tentative Agreement on 40% Pay Increase 
Anthropic Fights Pentagon Blacklisting in Dual Federal Court Battles 
UAE's Largest Natural Gas Facility Suspended After Attack-Triggered Fire 
Paramount Skydance Secures $24B from Gulf Sovereign Wealth Funds for Warner Bros. Discovery Takeover 
Samsung Electronics Posts Eightfold Profit Surge Driven by AI Chip Demand 
Disney Plans to Cut 1,000 Jobs Amid Ongoing Restructuring Efforts 
BHP's Incoming CEO Visits China Amid Pricing Dispute with CMRG 
LG Electronics Posts Record Q1 Revenue Amid Strong Demand and Cost Improvements 
Ford Issues Major Recall on Over 422,000 Vehicles Due to Windshield Wiper Defect 
Bendigo and Adelaide Bank Posts Strong Q3 Earnings, Announces AI-Driven Job Cuts 
SpaceX IPO: Retail Investors to Play Historic Role in Record-Breaking Public Offering 
UPS and Teamsters Reach Agreement to Limit Driver Severance Program 
Alibaba Shares Slide as Jefferies Slashes Price Target Over AI Spending and Business Losses 
Britain Courts Anthropic Amid US Defense Department Dispute 
China's AI Stocks Surge as Zhipu and MiniMax Hit Record Highs 
Chalco Stock Surges as Q1 2025 Profit Forecast Jumps Up to 58% 
NEW YORK, June 20, 2017 -- Luxury mattress manufacturer Unicorn Sleep says there is hope for patients with stage IV breast cancer.
“We believe in the power of research,” explained Unicorn Sleep CEO Chris Syed. “When properly funded, more life-extending treatments and therapies for stage IV breast cancer will be found.”
To help fund that research, Unicorn Sleep recently introduced a METAvivor mattress. The company donates 30 percent of profits from those sales to the charity METAvivor. METAvivor is a patient-led, non-profit organization that funds research, raises awareness, advocates for, and provides support to people with stage IV (metastatic) breast cancer.
“We at METAvivor are thrilled to partner with Unicorn Sleep. The generosity, care and concern of this company is humbling. Unicorn Sleep understands that research will make a difference for stage IV metastatic breast cancer. And for those patients who have bone metastasis it is really important to have a high quality mattress!” said METAvivor President Beth Fairchild.
Stage IV metastatic breast cancer (MBC) is defined by the spread of breast cancer to non-adjacent organs and is fatal in 97–99 percent of cases. In the U.S., more than 40,000 people die from MBC every year.
METAvivor awards grants for research projects that have the potential to shift MBC from a terminal disease to a chronic condition with a good quality of life. 100 percent of every donation given to METAvivor goes toward funding these grants.
“Unicorn Sleep was founded with the belief that good sleep is a vital part of good health and that giving back to the community is a responsibility we all share,” Syed explained. “The METAvivor mattress helps us achieve both.”
Unlike many direct-to-consumer mattress companies, Unicorn Sleep offers a choice of firmness. The handcrafted, 10-comfort-layer mattresses are built with the finest natural, high-quality components and include free white glove delivery and setup, removal, and a 150-night trial period—one of the longest in the industry.
About Unicorn Sleep
Unicorn Sleep produces all-natural, high-quality bedding products. Mattresses are delivered directly to the consumer via white glove delivery service and come with an industry-leading 150-night trial period. For more information, visit www.UnicornSleep.com.
Media Contact Jennifer Butsch Petit WordUp Public Relations [email protected] 757-656-9673
